Author: Zhao, Ling; Jha, Babal K.; Wu, Ashley; Elliott, Ruth; Ziebuhr, John; Gorbalenya, Alexander E.; Silverman, Robert H.; Weiss, Susan R.
Title: Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology Cord-id: zgdzd24d Document date: 2012_6_1
ID: zgdzd24d
Snippet: Many viruses induce hepatitis in humans, highlighting the need to understand the underlying mechanisms of virus-induced liver pathology. The murine coronavirus, mouse hepatitis virus (MHV), causes acute hepatitis in its natural host and provides a useful model for understanding virus interaction with liver cells. The MHV accessory protein, ns2, antagonizes the type I interferon response and promotes hepatitis. We show that ns2 has 2’,5’-phosphodiesterase activity, which blocks the interferon
Document: Many viruses induce hepatitis in humans, highlighting the need to understand the underlying mechanisms of virus-induced liver pathology. The murine coronavirus, mouse hepatitis virus (MHV), causes acute hepatitis in its natural host and provides a useful model for understanding virus interaction with liver cells. The MHV accessory protein, ns2, antagonizes the type I interferon response and promotes hepatitis. We show that ns2 has 2’,5’-phosphodiesterase activity, which blocks the interferon inducible 2’,5’-oligoadenylate synthetase (OAS)-RNase L pathway to facilitate hepatitis development. Ns2 cleaves 2’, 5’-oligoadenylate, the product of OAS, to prevent activation of the cellular endoribonuclease RNase L and consequently block viral RNA degradation. An ns2 mutant virus was unable to replicate in the liver or induce hepatitis in wild type mice, but was highly pathogenic in RNase L deficient mice. Thus, RNase L is a critical cellular factor for protection against viral infection of the liver and the resulting hepatitis.
Search related documents:
Co phrase search for related documents- abundant viral antigen and acute infection: 1
- accessory protein and activity assay: 1
- accessory protein and acute disease: 1, 2, 3, 4, 5
- accessory protein and acute hepatitis: 1, 2
- accessory protein and acute infection: 1, 2, 3, 4, 5, 6
- activity assay and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activity assay and acute hepatitis: 1
- activity assay and acute infection: 1, 2, 3, 4, 5
- activity assay and adaptive immune response: 1
- acute disease and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute infection and adaptive immune response defect: 1
Co phrase search for related documents, hyperlinks ordered by date